Research Papers

Performance of Biopsy Needle With Therapeutic Injection System to Prevent Bleeding Complications

[+] Author and Article Information
Philip Wong

MC3, Inc.,
3526 West Liberty, Suite 100,
Ann Arbor, MI 48103
e-mail: pwong@MC3corp.com

Kent J. Johnson

e-mail: kjjkjj@umich.edu

Roscoe L. Warner

e-mail: roscoew@umich.edu
Department of Pathology,
University of Michigan,
1301 Catherine, 7520 MSRBI,
Ann Arbor, MI 48109

Scott I. Merz

MC3, Inc.,
3526 West Liberty, Suite 100,
Ann Arbor, MI 48103
e-mail: smerz@MC3corp.com

Grant H. Kruger

Department of Mechanical Engineering,
University of Michigan,
2350 Hayward, 1031 H.H. Dow;
Department of Anesthesiology,
1500 E. Medical Center Dr., 1H247 UH,
Ann Arbor, MI 48109
e-mail: ghkruger@umich.edu

William F. Weitzel

Nephrology Division,
University of Michigan,
102 Observatory, 312 Simpson,
Ann Arbor, MI 48109;
VA Medical Center,
2215 Fuller Road,
Ann Arbor, MI 48105
e-mail: weitzel@umich.edu

1Corresponding author. Disclosure: William Weitzel has ownership interest in Arbor Ultrasound Technologies, LLC.

Manuscript received January 16, 2012; final manuscript received November 6, 2012; published online February 4, 2013. Assoc. Editor: Foster B. Stulen.

J. Med. Devices 7(1), 011002 (Feb 04, 2013) (7 pages) Paper No: MED-12-1007; doi: 10.1115/1.4023274 History: Received January 16, 2012; Revised November 06, 2012

Renal disease is epidemic in the United States with approximately 8 × 106 people having chronic kidney disease. Renal biopsies are widely used to provide essential diagnostic information to physicians. However, the risk of bleeding complications possibly leading to life-threatening situations results in the contra-indication of biopsy in certain patient populations. Safer renal biopsies will allow more accurate diagnosis and better management of this epidemic health problem. We report the preclinical testing of a novel biopsy device called the therapeutic injection system (TIS). The device introduces a third stage to the standard two-stage side-cut percutaneous biopsy process. The third stage is designed to reduce bleeding complications by injecting a hemostatic plug at the time of biopsy. Laboratory evaluation and preliminary in vivo animal testing using an anticoagulated porcine model of the TIS and Bard Monopty® (Bard Medical, Covington, GA) control device were performed. The hemostatic material Gelfoam® (Pfizer, Brussels, Belgium) was selected as the active material comprising the hemostatic plugs. The performance of two composite plugs, one composed of polyvinyl alcohol (PVA) combined in 2:1 and 12:1 ratios with the hemostatic material, and one plug composed of 100% hemostatic material were tested. Stroke sequence and hemostatic plug deployment were verified by sequential firing of the TIS biopsy needle into clear gelatin and ex vivo bovine kidney specimens. In vivo trials with porcine specimens revealed a significant reduction in blood loss (8.1 ± 3.9 ml, control versus 1.9 ± 1.6 ml, 12:1 PVA/hemostatic, TIS, α = 0.01, n = 6). The 100% hemostatic plug showed a substantial and immediate reduction in blood loss (9.2 ml, control versus 0.0 ml, TIS, n = 1). The prototype device was shown to work repeatedly and reliably in laboratory trials. Initial results show promise in this approach to control post biopsy bleeding. This solution maintains the simplicity and directness of the percutaneous approach, while not significantly changing the standard percutaneous biopsy procedure.

Copyright © 2013 by ASME
Your Session has timed out. Please sign back in to continue.


Manno, C., Strippoli, G. F., Arnesano, L.Bonifati, C., Campobasso, N., Gesualdo, L., and Schena, F. P., 2004, “Predictors of Bleeding Complications in Percutaneous Ultrasound-Guided Renal Biopsy,” Kidney Int., 66(4), pp. 1570–1577. [CrossRef] [PubMed]
Eiro, M., Katoh, T., and Watanabe, T., 2005, “Risk Factors for Bleeding Complications in Percutaneous Renal Biopsy,” Clin. Exp. Nephrol., 9(1), pp. 40–45. [CrossRef] [PubMed]
Shidham, G. B., Siddiqi, N., Beres, J. A., Logan, B., Nagaraja, H. N., Shidham, S. G., and Piering, W. F., 2005, “Clinical Risk Factors Associated With Bleeding After Native Kidney Biopsy,” Nephrology (Carlton), 10(3), pp. 305–310. [CrossRef] [PubMed]
Stratta, P., Canavese, C., Marengo, M., Mesiano, P., Besso, L., Quaglia, M., Bergamo, D., Monga, G., Mazzucco, G., and Ciccone, G., 2007, “Risk Management of Renal Biopsy: 1387 Cases Over 30 Years in a Single Centre,” Eur. J. Clin. Invest., 37(12), pp. 954–963. [CrossRef] [PubMed]
Orlando, C., Raggi, C. C., Bagnoni, L., Sestini, R., Briganti, V., La Cava, G., Bernini, G., Tonini, G. P., Pazzagli, M., Serio, M., and Maggi, M., 2001, “Somatostatin Receptor Type 2 Gene Expression in Neuroblastoma, Measured by Competitive Rt-Pcr, is Related to Patient Survival and to Somatostatin Receptor Imaging by Indium-111-Pentetreotide,” Med. Pediatr. Oncol., 36(1), pp. 224–226. [CrossRef] [PubMed]
Haaga, J., 1989, “Hemostatic Sheath for a Biopsy Needle and Method of Use,” U.S. Patent No. 4,838,280.
Haaga, J., 1992, “Medical Biopsy Needle,” U.S. Patent No. 5,080,655.
Haaga, J., 1996, “Biopsy System With Hemostatic Insert,” U.S. Patent No. 5,487,392.
Krause, W. R., 2004, “Biopsy and Delivery Device,” U.S. Patent No. 7,169,114.
Quinn, B., 1999, “Biopsy Needle Hub Assembly,” U.S. Patent No. 5,876,354.
Pruitt, T., Field, D., and Jacobs, C., 1999, “Automated Tissue Sampling Device,” U.S. Patent No. 5,993,399.
Zanelli, C., 2003, “Ultrasonic Based Detection of Interventional Medical Device Contact and Alignment,” U.S. Patent No. 6,546,276.
Matyas, J., and Rattner, J., 1999, “Method of Tissue Transfer and Retrieval,” U.S. Patent No. 5,858,781.
Gambale, R., 2007, “Tissue Capturing and Suturing Device and Method,” U.S. Patent No. 7,220,266.
Gambale, R., Shah, C., Weiser, M., Forcucci, S., and Forde, S., 2007, “Agent Delivery Systems,” U.S. Patent No. 7,232,421.
Breyer, B. N., McAninch, J. W., Elliott, S. P., and Master, V. A., 2008, “Minimally Invasive Endovascular Techniques to Treat Acute Renal Hemorrhage,” J. Urol., 179(6), pp. 2248–2252, Discussion 2253. [CrossRef] [PubMed]
Cluzel, P., Martinez, F., Bellin, M. F., Michalik, Y., Beaufils, H., Jouanneau, C., Lucidarme, O., Deray, G., and Grenier, P. A., 2000, “Transjugular Versus Percutaneous Renal Biopsy for the Diagnosis of Parenchymal Disease: Comparison of Sampling Effectiveness and Complications,” Radiology, 215(3), pp. 689–693. [PubMed]
Smith, T. P., Presson, T. L., Heneghan, M. A., and Ryan, J. M., 2003, “Transjugular Biopsy of the Liver in Pediatric and Adult Patients Using an 18-Gauge Automated Core Biopsy Needle: A Retrospective Review of 410 Consecutive Procedures,” AJR Am. J. Roentgenol., 180(1), pp. 167–172. [CrossRef] [PubMed]
Abbott, K. C., Musio, F. M., Chung, E. M., Lomis, N. N., Lane, J. D., and Yuan, C. M., 2002, “Transjugular Renal Biopsy in High-Risk Patients: An American Case Series,” BMC Nephrol., 3, p. 5. [CrossRef] [PubMed]
Shetye, K. R., Kavoussi, L. R., Ramakumar, S., Fugita, O. E., and Jarrett, T. W., 2003, “Laparoscopic Renal Biopsy: A 9-Year Experience,” BJU Int., 91(9), pp. 817–820. [CrossRef] [PubMed]
Hatfield, M. K., Beres, R. A., Sane, S. S., and Zaleski, G. X., 2008, “Percutaneous Imaging-Guided Solid Organ Core Needle Biopsy: Coaxial Versus Noncoaxial Method,” AJR Am. J. Roentgenol., 190(2), pp. 413–417. [CrossRef] [PubMed]


Grahic Jump Location
Fig. 2

TIS prototype showing (a) complete device (38 cm long) and (b) stylet tip with channel for hemostatic plug

Grahic Jump Location
Fig. 1

TIS biopsy needle deployment sequence (not to scale)

Grahic Jump Location
Fig. 3

TIS deployment sequence with scale (cm), showing (a) prefiring, (b) hemostatic plug exiting needle, and (c) hemostatic plug deployed

Grahic Jump Location
Fig. 4

Stained and sectioned biopsy taken with TIS device

Grahic Jump Location
Fig. 6

Renal cortical tissue sections from in vivo porcine experiment for animal 2 (scale is in cm with 1 mm resolution)

Grahic Jump Location
Fig. 7

Histology of biopsy sections with hematoxylin and eosin staining

Grahic Jump Location
Fig. 5

Blood loss (ml) versus time (s). Error bars represent ±1 standard deviation.




Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging and repositioning the boxes below.

Related Journal Articles
Related eBook Content
Topic Collections

Sorry! You do not have access to this content. For assistance or to subscribe, please contact us:

  • TELEPHONE: 1-800-843-2763 (Toll-free in the USA)
  • EMAIL: asmedigitalcollection@asme.org
Sign In